Logo
x

Search category

Subscribe Now

Senju Pharmaceutical

Senju Pharmaceutical Highlighted Study Results of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration

Senju Pharmaceutical Highlighted Study Results of Ranibizumab Biosimilar for Neovascular Age-Related Macular Degeneration

  • August 15, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.